Hearing on "Responding to America’s Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act"

The Subcommittee on Health of the Committee on Energy and Commerce held a hearing on Wednesday, June 21, 2023, at 10 a.m. in 2322 Rayburn House Office Building. The hearing is entitled, “Responding to America’s Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act.”

Key Documents

Opening Statement from Ranking Member Pallone as prepared for delivery

Opening Statement from Subcommittee Ranking Member Eshoo as prepared for delivery 

Livestream

Legislation

H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023

H.R. 3892,the Improving Mental Health and Drug Treatment Act

H.R. 4091, the Combatting Substance Use Disorder Act

H.R. 3736, the Extending Access to Addiction Treatment Act

H.R. 4096, To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries

H.R. 4056,the Ensuring Medicaid Continuity for Children in Foster Care Act of 2023

H.R. 3074, the Due Process Continuity of Care Act

H.R. 2400, the Reentry Act of 2023

H.R. 4089, the Safer Response Act

H.R. 4063,the FIND Fentanyl Act of 2023

H.R. 4079,the Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023

H.R. 4100, To amend the Public Health Service Act to reauthorize a monitoring and education program regarding infections associated with illicit drug use and other risk factors.

H.R. 4101, the Road to Recovery Act 

H.R. 4099, the RECONNECTS Act of 2023 

H.R. 4088, the CAREER Act

H.R. 1502, the Comprehensive Opioid Recovery Centers Reauthorization Act of 2023

H.R. 4098, the Communities of Recovery Reauthorization Act

H.R. 4095, the Save Children from Trauma Act

H.R. 4097,the Mental Health Improvement Act

H.R. 1839,the Combating Illicit Xylazine Act

H.R. 4053, the Studying Suboxone Act

H.R.__, To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips.

H.R. 4057,the Keeping Kids Safe Act

H.R. 4080,the Trauma-Informed Care Task Force Reauthorization Act of 2023

H.R. 4092,the Protecting Moms and Infants Reauthorization Act

H.R. 4054, the Trauma Support and Mental Health in Schools Reauthorization Act 

H.R. 4093, the Remote Opioid Monitoring Act of 2023

H.R. 4007, the HEAL Act

Witnesses

Matthew Strait
Deputy Assistant Administrator, Office of Diversion Control
Drug Enforcement Administration

Testimony

Christopher Jones, PharmD, DrPH, MPH
Director of the National Office of Injury Prevention and Control
Centers for Disease Control and Prevention

Testimony

Tom Coderre
Acting Deputy Assistant Secretary for Mental Health and Substance Use
U.S. Department of Health and Human Services

Testimony

Diana Espinosa, MPP
Principal Deputy Administrator of the Health Resources and Services Administration
Acting Deputy Assistant Secretary for Mental Health and Substance Use
U.S. Department of Health and Human Services

Testimony

Jonathan Blum, MPP
Principal Deputy Administrator and Chief Operating Officer
Centers for Medicare and Medicaid Services

Testimony